2C-T-21 Facts
Psychedelic;
Description
2C-T-21 (2,5-dimethoxy-4-(2-fluoroethylthio)phenethylamine) — also known as Aurora — is a synthetic psychedelic of the phenethylamine class. It activates serotonin receptors in the brain, disrupting normal filtering of sensory and emotional input to produce psychedelic effects.
Subjective effects include tactile enhancement, mood elevation, social euphoria, increased communicativeness, and brightened colors. The experience is defined by empathogenic warmth — a sustained, gently stimulating sociability — rather than intense visuals or perceptual destabilization.
2C-T-21 does not produce physical dependence, and no lethal dose has been established, though deaths have occurred within the broader 2C-T class.[1][2] The main danger is drug interactions — 2C-T-21 inhibits serotonin-clearing enzymes,[3] making combinations with antidepressants or monoamine oxidase-inhibiting plants potentially life-threatening.
Dose and durationby route · individual sensitivity varies
Starts in 90 – 120 minLasts 7 – 12 hoursAfter-effects 2 – 4 hours
Body and dependence
- Acute toxicity
- Moderate
- Chronic toxicity
- Moderate
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 7 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT; 2C-B; 2C-T-2; 2C-T-7
Effectslikely at a common dose
- Perception
- Music enhancement;
Visual drifting; Brightness alteration; Geometry; Visual breathing; Color enhancement; Color alteration; +22 possible, including Visual haze / noise, Spatial disorientation, Visual acuity suppression - Body
- Body high;
Body scan awareness; Spontaneous body sensations; Pupil dilation; +32 possible, including Muscle tension, Nausea, Heart rate perception changes - Thinking
- Pattern recognition enhancement;
Aesthetic enhancement; Introspection enhancement; Openness enhancement; Thought connectivity; Novelty enhancement; Conceptual thinking; +25 possible, including Decision impairment, Suggestibility enhancement, Cognitive impairment - Feeling
- Emotional enhancement;
+6 possible, including Emotional lability, Anxiety - Self
- none likely · 9 possible, including Derealization, Depersonalization
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 4 possible
Who shouldn't take it
Combinations60 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Schifano F, Deluca P, Agosti L, Martinotti G, Corkery JM, et al. (2005) New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic') — Journal of Psychopharmacology PMID:16272191
- [2]^Dean BV, Stellpflug SJ, Burnett A, Engebretsen KM (2013) 2C or Not 2C: Phenethylamine Designer Drug Review — Journal of Medical Toxicology doi:10.1007/s13181-013-0295-x
- [3]^Wagmann L, Brandt SD, Stratford A, Maurer HH, Meyer MR (2019) Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases — Drug Testing and Analysis doi:10.1002/dta.2494